Naik-Nimbalkar had joined the Sharad Pawar-led NCP (SP) along with then-sitting Phaltan legislator Deepak Chavan just before ...

Twelve days after chief minister Devendra Fadnavis put on hold the appointment of guardian ministers in Raigad and Nashik ...

Speculation is rife that eight MPs and ten MLAs from the Nationalist Congress Party (NCP), led by Sharad Pawar, are poised to join Deputy Chief Minister Ajit Pawar's faction. Reports suggest these ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

Ajit Pawar reaffirmed NCP's commitment to secularism and its stance against welcoming individuals with questionable reputations. He urged party members to uphold this principle. Pawar also ...

Chhatrapati Sambhajinagar: NCP on Wednesday dissolved its Beed district committee after Vishnu Chate, the party's Kaij taluka president, was linked to the abduction-murder of Massajog village ...

Nesvold Capital Partners LLC ("NCP"), a leading merchant bank specializing in the wealth management sector and its broader ecosystem, is pleased to announce the appointment of Mark Tibergien, former ...

The Sharad Pawar faction of the NCP denies joining the BJP-led coalition in Maharashtra, accusing the Ajit Pawar faction of attempting to poach their MPs. They dismissed claims of unifying with the ...

In a major development, sources claimed that Ajit Pawar's Nationalist Congress Party (NCP) is likely to contest the upcoming MumbiaBMC elections alone. Meanwhile, the BJP and Eknath Shinde's Shiv ...

Sanjay Raut alleges the Ajit Pawar-led NCP is trying to cause defections in Sharad Pawar's NCP by promising cabinet positions. Jitendra Awhad claims Sunil Tatkare urged MPs to abandon Sharad Pawar and ...

The onset of 2025 seems to have brought glad tidings for Maharashtra Chief Minister Devendra Fadnavis. As the tussle between the three partners of the ruling Mahayuti coalition – the BJP, Shiv Sena ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...